BioMarin Pharmaceutical (BMRN)’s Alesta Deal Adds New Growth Potential in Rare Diseases
finance.yahoo.com
20.08.2026 00:02
30 views
Related stories
Oil price on track for longest losing streak in more than 12 months
ft.com · 23.09
Oil tanker costs hit record $1.2mn a day as Iran war disrupts shipping
ft.com · 23.09
The battle between the Fed and Trump
ft.com · 23.09
Nvidia-backed Nscale buried ByteDance deal in push to $35bn IPO
ft.com · 23.09
China takes stock of Broadcom gear amid domestic AI drive
ft.com · 23.09
How private equity ended up in limbo
ft.com · 23.09